Martha Skinner, M.D.

Skinner pic_red shirtProfessor Emerita

Interim DirectorAmyloidosis Center

Director of Special Projects, Amyloidosis Center

Director (1988-2007),
Amyloid Treatment & Research Program

Affiliation: Department of Medicine, Section of Rheumatology


  • Medical College of Pennsylvania
  • Fellowship: Boston University School of Medicine, Rheumatology

Positions and Honors

  • President-Elect, International Society of Amyloidosis
  • Associate Editor, Amyloid: International Journal of Experimental and Clinical Investigation

Research interests:
Treatment and research of amyloid diseases.

Selected Publications (from 350):

  • Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G:  A framework for clinical research in systemic light-chain (AL) amyloidosis: consensus report of the first Amyloidosis Foundation roundtable.  Leukemia, in press 2012.
  • Seldin DC, Skinner M: Amyloidosis, In Kelly’s Textbook of Rheumatology, 9th edition, Ed by S Ruddy, CB Sledge, JS Sargent, RC Budd.  Elsevier, Philadelphia, in press, 2012.
  • Skinner M: Editorial, The International Society of Amyloidosis: brief comments on our Symposia and our Society.  Amyloid: J Prot Folding Disorders.  19:3-4, 2012.
  • Charlot M, Seldin DC, O’Hara C, Skinner M, Sanchorawala V:  Localized amyloidosis of the breast:  a case series.  Amyloid: J Prot Folding Disorders, 18: 72-75, 2011.
  • Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea N, Sloan JM, Finn K, Doros G, Blade J, Skinner M:  Outcome of AL amyloidosis after high-dose melphalan and autologous stem-cell transplantation: long-term results in a series of 421 patients. Blood, 118:4346-4352, 2011.
  • Cowan AJ, Skinner M, Berk JL, Sloan JM, O’Hara C, Seldin DS, Sanchorawala V:  Macroglossia—not always AL amyloidosis. Amyloid: J. Prot Folding Disorders, 18: 83-86, 2011.
  • Girnius S, Dember L, Doros G, Skinner M:  The changing face of AA amyloidosis: a single center experience.  XIIth International Symposium on Amyloidosis, 18, suppl 1:226-228, 2011.
  • Seldin DC, Skinner M: Amyloidosis, in Harrison’s Principles of Internal Medicine, 18th edition, Ed. By DL Longo, AS Fauci, DL Kasper, SK Hauser, JL Jameson, J Loscalzo. McGraw-Hill, New York, pp 945-950, 2011.
  • Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert H, O’Connell R, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, and Sanchorawala V:  High dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and one-year survival at a single institution.  XIIth International Symposium on Amyloidosis, 18, suppl 1:127-129, 2011.
  • Skinner M: Book review, Amyloidosis: Diagnosis and Treatment, Ed by M Gertz, V Rajkumar. Europ J Heme, 88:360, 2011.
  • Dey BR, Chung S, Spitzer TR, Zheng H, MacGillivray TE, Seldin DC, MsAfee S, Ballen K, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, Madsen JC, Semigran MJ:  Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for AL amyloidosis and heart failure. Transplantation, 90:905-911, 2010.
  • Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V:  Short and long term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis.  Annals of Hematology, 89:579-584, 2010.
  • Klimtchuk ES, Gursky O, Patel R, Laporte KL, Connors LH, Skinner M, Seldin DC:  The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain.  Biochemistry, 49: 9848-9857, 2010.
  • Rosenzweig M, Seldin DC, Remick DG, Skinner M, Quillen K, Oran B, F Febrile reactions occurring with second cycle of high dose melphalan and stem cell transplantation in patients with AL amyloidosis: a “melphalan recall” reaction.  Bone Marrow Transplantation, 45: 21-24, 2010.
  • Sanchorawala V, Seldin DC, Berk JL, Sloan M, Doros G, Skinner M:  Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis.  Clin. Lymphoma, Myeloma, Leukemia 10: 469-472, 2010.
  • Skinner M, Merlini G:  Introducing the new editor of Amyloid:  the journal of protein folding disorders, Per Westermark, M.D, Ph.D.  Amyloid: J Prot Folding Disorders, 17: 99-100, 2010.